ÂÜÀòÂÒÂ×

Mark Campbell has a diverse work experience. Mark is currently the Chief Operating Officer at Emvenio Research since August 2022. Prior to this, they worked as a Strategic Advisor at Alere Pharma Consulting from January 2021. From January 2020 to January 2021, they served as the Executive Vice President at mdgroup.

From 2014 to 2019, Mark worked at Accelerated Enrollment Solutions, where they held various roles including Vice President of Operational and Strategic Solutions from August 2018 to October 2019, and Vice President of Programme Management from January 2014 to August 2018.

Mark also has experience as the Founder & Managing Director of Osmovian Limited from May 2010 to June 2016. Mark worked as a Project Management Consultant at Amgen from March 2011 to November 2013, and as a Clinical Outsourcing and Contract Management Consultant at Fresenius Biotech GmbH from January 2011 to May 2011.

Earlier in their career, Mark held leadership positions at Quanticate, where they served as the Head of Project Management from September 2006 to May 2010, and as the Head of Clinical Data Management from September 2006 to May 2007. Mark also worked at Johnson & Johnson as an International Project Leader from May 1999 to September 2006.

Mark Campbell has a strong educational background in project management. Mark obtained a Bachelor of Science Honors degree in Programme & Project Management from Leeds Beckett University between 2003 and 2006. Following this, they furthered their education at the same institution by completing a Postgraduate Certificate in Strategic Project Management from 2009 to 2010. Finally, they pursued a Master's degree in Strategic Project Management from Leeds Beckett University between 2010 and 2013, further emphasizing their commitment to the field of project management.